The role and prospects of oxytocin in peripartum depression
10.3760/cma.j.cn113903-20231018-00266
- VernacularTitle:缩宫素在围产期抑郁中的作用及应用前景
- Author:
Qiyin LI
1
;
Saidi PU
;
Wei ZHOU
Author Information
1. 重庆医科大学附属妇女儿童医院睡眠心理科，重庆 401147
- Publication Type:Journal Article
- Keywords:
Oxytocin;
Depression, perinatal;
Biomarkers;
Review
- From:
Chinese Journal of Perinatal Medicine
2024;27(12):1107-1111
- CountryChina
- Language:Chinese
-
Abstract:
Oxytocin has a positive emotional regulatory effect on the human body, and its level fluctuates significantly during the perinatal period compared to normal physiological states. Therefore, oxytocin holds promise as a quantitative indicator specific to the perinatal period for screening and diagnosing depression. Oxytocin is the first-line medication for the prevention and treatment of postpartum hemorrhage. However, considering the potential negative impacts of its intravenous application on women with perinatal depression and their offspring, strict control of the timing and dosage of medication may be beneficial for the prevention and treatment of perinatal depression. This article reviews the role and prospects of oxytocin in perinatal depression.
